Feb 25, 2026 06:40AM
Feb 24, 2026 05:15PM
Jan 27, 2026 05:18PM
Jan 21, 2026 05:18AM
Jan 16, 2026 07:02AM
Jan 13, 2026 07:11AM
Jan 13, 2026 07:11AM Apellis Pharmaceuticals (APLS) Reiterated at Overweight by Cantor Fitzgerald
Jan 12, 2026 01:45PM
Jan 2, 2026 10:00PM
Dec 21, 2025 08:00PM
Dec 19, 2025 07:31AM
Dec 15, 2025 04:30AM
Nov 12, 2025 07:02AM
Nov 3, 2025 06:41AM Apellis Pharmaceuticals (APLS) PT Lowered to $19 at Mizuho
Oct 30, 2025 08:17AM
Oct 21, 2025 06:47AM
Oct 20, 2025 05:12AM
Oct 20, 2025 05:08AM
Oct 15, 2025 05:11AM
Sep 29, 2025 06:58AM
Sep 26, 2025 05:08AM Goldman Sachs Downgrades Apellis Pharmaceuticals (APLS) to Sell
Aug 1, 2025 08:40AM
Jul 31, 2025 07:09AM
Jul 30, 2025 08:34AM
Jul 29, 2025 12:12PM
Jul 29, 2025 08:36AM
Jul 29, 2025 07:07AM
Jul 14, 2025 06:56AM H.C. Wainwright Reiterates Buy Rating on Apellis Pharmaceuticals (APLS)
Jul 10, 2025 07:28AM
Jul 10, 2025 06:40AM
Jul 2, 2025 06:36AM
Jul 1, 2025 12:03PM
Jul 1, 2025 07:03AM
Jun 6, 2025 09:16AM
Jun 2, 2025 05:53AM Apellis Pharmaceuticals (APLS) PT Raised to $29 at Wells Fargo
May 25, 2025 03:00PM
May 21, 2025 04:54PM
May 9, 2025 05:16AM
May 7, 2025 07:08AM
Apr 29, 2025 06:32AM
Apr 21, 2025 07:02AM
Apr 1, 2025 07:01AM Apellis Pharmaceuticals (APLS) Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
Mar 3, 2025 07:56AM
Feb 28, 2025 03:25PM
Feb 28, 2025 03:06PM
Feb 28, 2025 07:11AM
Feb 13, 2025 06:02AM
Feb 12, 2025 09:55AM
Jan 28, 2025 12:16PM Mizuho Reiterates Neutral Rating on Apellis Pharmaceuticals (APLS)
Jan 27, 2025 04:00PM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All